Literature DB >> 31118121

Design of in vitro Transcribed mRNA Vectors for Research and Therapy.

Marina Tusup, Lars E French, Mara De Matos, David Gatfield, Thomas Kundig, Steve Pascolo.   

Abstract

The use of in vitro transcribed messenger RNA (ivt mRNA) for vaccination, gene therapy and cell reprograming has become increasingly popular in research and medicine. This method can be used in vitro (transfected in cells) or administered naked or formulated (lipoplexes, polyplexes, and lipopolyplexes that deliver the RNA to specific organs, such as immune structures, the lung or liver) and is designed to be an immunostimulatory or immunosilent agent. This vector contains several functional regions (Cap, 5' untranslated region, open reading frame, 3' untranslated region and poly-A tail) that can all be optimised to generate a highly efficacious ivt mRNA. In this study, we review these aspects and report on the effect of the ivt mRNA purification method on the functionality of this synthetic transient genetic vector.

Mesh:

Substances:

Year:  2019        PMID: 31118121     DOI: 10.2533/chimia.2019.391

Source DB:  PubMed          Journal:  Chimia (Aarau)        ISSN: 0009-4293            Impact factor:   1.509


  7 in total

1.  Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.

Authors:  Attya Omer-Javed; Gabriele Pedrazzani; Luisa Albano; Sherash Ghaus; Claire Latroche; Maura Manzi; Samuele Ferrari; Martina Fiumara; Aurelien Jacob; Valentina Vavassori; Alessandro Nonis; Daniele Canarutto; Luigi Naldini
Journal:  Cell       Date:  2022-05-25       Impact factor: 66.850

Review 2.  mRNA vaccines manufacturing: Challenges and bottlenecks.

Authors:  Sara Sousa Rosa; Duarte M F Prazeres; Ana M Azevedo; Marco P C Marques
Journal:  Vaccine       Date:  2021-03-24       Impact factor: 4.169

Review 3.  mRNA in cancer immunotherapy: beyond a source of antigen.

Authors:  Karine Breckpot; Sandra Van Lint; Lien Van Hoecke; Rein Verbeke; Heleen Dewitte; Ine Lentacker; Karim Vermaelen
Journal:  Mol Cancer       Date:  2021-03-03       Impact factor: 27.401

4.  Maximizing mRNA vaccine production with Bayesian optimization.

Authors:  Sara Sousa Rosa; Davide Nunes; Luis Antunes; Duarte M F Prazeres; Marco P C Marques; Ana M Azevedo
Journal:  Biotechnol Bioeng       Date:  2022-09-05       Impact factor: 4.395

Review 5.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

6.  Functional differences between protamine preparations for the transfection of mRNA.

Authors:  Natalia Teresa Jarzebska; Severin Lauchli; Christoph Iselin; Lars E French; Pal Johansen; Emmanuella Guenova; Thomas M Kündig; Steve Pascolo
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 7.  mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Authors:  Andreas Ouranidis; Theofanis Vavilis; Evdokia Mandala; Christina Davidopoulou; Eleni Stamoula; Catherine K Markopoulou; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Biomedicines       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.